IFP Advisors’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Hold |
0
| – | -$435 | – | 3240 |
|
2025
Q1 | – | Hold |
0
| – | -$505 | – | 3494 |
|
2024
Q4 | – | Hold |
0
| – | – | – | 3414 |
|
2023
Q4 | – | Sell |
-73
| Closed | -$2.6K | – | 3282 |
|
2023
Q3 | $2.6K | Hold |
73
| – | – | ﹤0.01% | 2756 |
|
2023
Q2 | $3.37K | Hold |
73
| – | – | ﹤0.01% | 2680 |
|
2023
Q1 | $5.18K | Sell |
73
-155
| -68% | -$11K | ﹤0.01% | 2551 |
|
2022
Q4 | $16K | Buy |
228
+86
| +61% | +$6.04K | ﹤0.01% | 3077 |
|
2022
Q3 | $10K | Hold |
142
| – | – | ﹤0.01% | 3668 |
|
2022
Q2 | $10K | Hold |
142
| – | – | ﹤0.01% | 3423 |
|
2022
Q1 | $10K | Buy |
+142
| New | +$10K | ﹤0.01% | 3423 |
|
2021
Q3 | – | Sell |
-4
| Closed | – | – | 4307 |
|
2021
Q2 | $0 | Sell |
4
-10
| -71% | – | ﹤0.01% | 4080 |
|
2021
Q1 | $2K | Sell |
14
-18
| -56% | -$2.57K | ﹤0.01% | 2672 |
|
2020
Q4 | $4K | Buy |
32
+22
| +220% | +$2.75K | ﹤0.01% | 2410 |
|
2020
Q3 | $1K | Buy |
+10
| New | +$1K | ﹤0.01% | 2665 |
|
2020
Q2 | – | Hold |
0
| – | – | – | 3510 |
|
2020
Q1 | – | Hold |
0
| – | – | – | 3449 |
|
2019
Q4 | – | Hold |
0
| – | – | – | 3446 |
|
2019
Q3 | – | Hold |
0
| – | – | – | 3515 |
|
2018
Q4 | – | Sell |
-14
| Closed | -$1K | – | 3756 |
|
2018
Q3 | $1K | Hold |
14
| – | – | ﹤0.01% | 3670 |
|
2018
Q2 | $1K | Buy |
+14
| New | +$1K | ﹤0.01% | 3708 |
|
2017
Q4 | – | Sell |
-4
| Closed | – | – | 4001 |
|
2017
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 4136 |
|
2017
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 4145 |
|
2017
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 4066 |
|
2016
Q4 | $0 | Hold |
4
| – | – | ﹤0.01% | 4077 |
|
2016
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 3993 |
|
2016
Q2 | $0 | Buy |
+4
| New | – | ﹤0.01% | 4121 |
|
2016
Q1 | – | Sell |
-11
| Closed | -$1K | – | 3200 |
|
2015
Q4 | $1K | Buy |
+11
| New | +$1K | ﹤0.01% | 3529 |
|